Pfizer COVID-19 Vaccine Trial Diversity Slips As Enrollment Rises, Unlike Moderna
Executive Summary
Trial diversity is among the issues that stakeholders worry could hinder vaccine uptake.
You may also be interested in...
Cavazzoni Appeals For Pragmatic Approach To Clinic Trial Diversity Plans
In another attempt to address concerns about the new mandate, the director of the US FDA’s Center for Drug Evaluation and Research said the agency must balance its interest in trial diversity with the need to get treatments to patients as soon as possible.
Clinical Trial Diversity Plans: Will US FDA Offer A Gentle Enforcement Hand?
New guidance is due in a few months that should answer questions about how the FDA will react if a sponsor does not reach its clinical trial diversity goals.
Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals
No negative actions have been taken in the US FDA’s oncology review divisions, but vague diversity guidance continues to raise concerns.